Literature DB >> 35355842

Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?

Zoe N Memel1,2, Jeffrey Wang3, Kathleen E Corey1,2,3.   

Abstract

Content available: Author Interview and Audio Recording.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 35355842      PMCID： PMC8958240          DOI： 10.1002/cld.1172

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  9 in total

1.  Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease.

Authors:  Sara Ebrahimi; Bahram Pourghassem Gargari; Fereshteh Aliasghari; Foad Asjodi; Azimeh Izadi
Journal:  Int J Vitam Nutr Res       Date:  2019-04-01       Impact factor: 1.784

2.  Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota.

Authors:  Guolin Li; Cen Xie; Siyu Lu; Robert G Nichols; Yuan Tian; Licen Li; Daxeshkumar Patel; Yinyan Ma; Chad N Brocker; Tingting Yan; Kristopher W Krausz; Rong Xiang; Oksana Gavrilova; Andrew D Patterson; Frank J Gonzalez
Journal:  Cell Metab       Date:  2017-11-07       Impact factor: 27.287

3.  Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet.

Authors:  Megumi Hatori; Christopher Vollmers; Amir Zarrinpar; Luciano DiTacchio; Eric A Bushong; Shubhroz Gill; Mathias Leblanc; Amandine Chaix; Matthew Joens; James A J Fitzpatrick; Mark H Ellisman; Satchidananda Panda
Journal:  Cell Metab       Date:  2012-05-17       Impact factor: 27.287

Review 4.  Effects of Intermittent Fasting on Health, Aging, and Disease.

Authors:  Rafael de Cabo; Mark P Mattson
Journal:  N Engl J Med       Date:  2019-12-26       Impact factor: 91.245

5.  The Effects of Ramadan Fasting on Body Composition, Blood Pressure, Glucose Metabolism, and Markers of Inflammation in NAFLD Patients: An Observational Trial.

Authors:  Fereshteh Aliasghari; Azimeh Izadi; Bahram Pourghassem Gargari; Sara Ebrahimi
Journal:  J Am Coll Nutr       Date:  2017-09-18       Impact factor: 3.169

6.  The Impact of Ramadan Fasting on Fatty Liver Disease Severity: A Retrospective Case Control Study from Israel.

Authors:  Amir Mari; Tawfik Khoury; Mahamid Baker; Halel Said Ahmad; Fadi Abu Baker; Mahmud Mahamid
Journal:  Isr Med Assoc J       Date:  2021-02       Impact factor: 0.892

7.  Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial.

Authors:  Hua Cai; Yue-Lan Qin; Ze-Ya Shi; Jin-Hui Chen; Min-Jie Zeng; Wei Zhou; Ru-Qun Chen; Zhi-Yuan Chen
Journal:  BMC Gastroenterol       Date:  2019-12-18       Impact factor: 3.067

8.  A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease.

Authors:  Muhammad Izzad Johari; Khairiah Yusoff; Juhara Haron; Chandran Nadarajan; Khairun Nisah Ibrahim; Mung Seong Wong; Muhammad Ilham Abdul Hafidz; Bee Eng Chua; Nurhazwani Hamid; Wan Nor Arifin; Zheng Feei Ma; Yeong Yeh Lee
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

9.  Effects of Periodic Fasting on Fatty Liver Index-A Prospective Observational Study.

Authors:  Stefan Drinda; Franziska Grundler; Thomas Neumann; Thomas Lehmann; Nico Steckhan; Andreas Michalsen; Francoise Wilhelmi de Toledo
Journal:  Nutrients       Date:  2019-10-30       Impact factor: 5.717
  9 in total
  2 in total

1.  Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial.

Authors:  Hamed Kord Varkaneh; Ammar Salehi Sahlabadi; Mihnea-Alexandru Găman; Mohsen Rajabnia; Melahat Sedanur Macit-Çelebi; Heitor O Santos; Azita Hekmatdoost
Journal:  Front Nutr       Date:  2022-07-26

Review 2.  Obesity, cancer risk, and time-restricted eating.

Authors:  Manasi Das; Nicholas J G Webster
Journal:  Cancer Metastasis Rev       Date:  2022-08-19       Impact factor: 9.237
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.